Targretin

Product manufactured by Bausch Health Us, Llc

Application Nr Approved Date Route Status External Links
NDA021056 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Targretin (Bexarotene) Gel 1% Is Indicated For The Topical Treatment Of Cutaneous Lesions In Patients With Ctcl (Stage Ia And Ib) Who Have Refractory Or Persistent Disease After Other Therapies Or Who Have Not Tolerated Other Therapies.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Bexarotene BEXAROTENE ZINC1539579

Comments